Stay updated on Incyte Press Releases
Sign up to get notified when there's something new on the Incyte Press Releases page.

Latest updates to the Incyte Press Releases page
- Check2 days agoChange DetectedAdds a September 10, 2025 Incyte data presentation at a dermatology congress and removes the prior June 26, 2025 leadership announcement.SummaryDifference19%
- Check9 days agoChange DetectedThe page has added information about Incyte's launch of HS TRUTHS, while it has removed an update regarding the FDA review of Ruxolitinib Cream for children.SummaryDifference17%
- Check16 days agoChange DetectedThe page has added a new executive appointment at Incyte, while significant announcements regarding FDA approvals and collaborations have been removed.SummaryDifference100%
- Check23 days agoChange DetectedThe page now includes an announcement about Incyte presenting at upcoming investor conferences, while a previous announcement regarding positive data for a specific therapy has been removed.SummaryDifference13%
- Check38 days agoChange DetectedThe page has updated to reflect the departure of Incyte's Chief Financial Officer, Christiana Stamoulis, while removing a previous announcement regarding Phase 3 data for Retifanlimab.SummaryDifference16%
- Check45 days agoChange DetectedThe webpage has updated its financial reporting date to July 29, 2025, and removed a previous report from June 6, 2025.SummaryDifference13%
Stay in the know with updates to Incyte Press Releases
Enter your email address, and we'll notify you when there's something new on the Incyte Press Releases page.